Another strategy worthy of study would rely on exploiting defined activating receptors (i.e., TLRs) on the surface of MCs instead of IgE/FcεRI activation in order to trigger the release of desired mediators when cognate ligands are expressed by tumor cells or the surrounding TME. The gene discussed is IGHE; the disease is neoplasm.